MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and Esophageal cancer

被引:78
作者
Komoto, Chiho
Nakamura, Tsutomu
Sakaeda, Toshiyuki
Kroetz, Deanna L.
Yamada, Toshio
Omatsu, Hideaki
Koyama, Tatsuya
Okamura, Noboru
Miki, Ikuya
Tamura, Takao
Aoyama, Nobuo
Kasuga, Masato
Okumura, Katsuhiko
机构
[1] Kobe Univ, Sch Med, Kobe, Hyogo 650, Japan
[2] Kobe Univ, Grad Sch Med, Dept Gen Therapeut, Div Clin Pharmacokinet, Kobe, Hyogo 657, Japan
[3] Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Diabet Digest & Kidney Dis, Kobe, Hyogo 657, Japan
[4] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA
[6] Kobe Univ, Grad Sch Med, Dept Clin Evaluat Pharmacotherapy, Kobe, Hyogo 657, Japan
关键词
MDR1; genotype; haplotype; inter-ethnic difference; colorectal cancer; esophageal cancer;
D O I
10.2133/dmpk.21.126
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The genotype frequencies of MDR1 T-129C, C1236T, G2677A,T and C3435T SNPs were compared in 154 healthy Japanese and 100 healthy Caucasians to provide basic information on the interethnic differences of pharmacotherapeutic outcome. The variants were found at allelic frequencies of 5.5%, 65.6%, 16.6%, 40.6% and 40.6%, for T-129C, C1236T, G2677A, G2677T and C3435T, respectively, in Japanese, and at 5.1%, 45.9%, 3.6%, 46.4% and 56.6%, respectively, in Caucasians, with a statistically significant difference for C1236T, G2677A,T and C3435T (p < 0.001). G2677A was about 5-fold more frequent in Japanese than Caucasians. These genotype frequencies were also investigated in 95 Japanese patients with colorectal cancer (CRC) and esophageal squamous cell carcinoma (ESCC), but no significant difference was detected, when compared with healthy Japanese subjects. The haplotype frequency reached a total of about 85% in Japanese with the following 4 major haplotypes; T-129-T-1236-T-2677-T-3435(36.1%), T-129-T-1236-G(2677)C(3435) (22.5%), T-129-C-1236-G(2677)-C-3435 (14.2%) and T-129-C-1236-A(2677)-C-3435 (13.3%). The second and fourth haplotypes were hardly inferred in Caucasian, whereas T-129-C-1236-G(2677)-T-3435 (12.8%) was found to be Caucasian-specific. There was a tendency for higher frequencies of the T-129/C-(129)-C-1236-A(2677)-C-3435 haplotype in Japanese CRC patients and T-(129)-T-1236-T-2677-T-3435 haplotype in Japanese ESCC patients, compared with that in healthy Japanese subjects.
引用
收藏
页码:126 / 132
页数:7
相关论文
共 34 条
[1]   Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects (vol 69, pg 169, 2001) [J].
Cascorbi, I ;
Gerloff, T ;
Johne, A ;
Meisel, C ;
Hoffmeyer, S ;
Schwab, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (01) :124-124
[2]   Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo [J].
Colombo, S ;
Soranzo, N ;
Rotger, M ;
Sprenger, R ;
Bleiber, G ;
Furrer, H ;
Buclin, T ;
Goldstein, D ;
Décosterd, L ;
Telenti, A .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (09) :599-608
[3]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[4]   Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677:: Functional relevance to pharmacokinetics of digoxin [J].
Horinouchi, M ;
Sakaeda, T ;
Nakamura, T ;
Morita, Y ;
Tamura, T ;
Aoyama, N ;
Kasuga, M ;
Okumura, K .
PHARMACEUTICAL RESEARCH, 2002, 19 (10) :1581-1585
[5]  
Humeny A, 2003, ANTICANCER RES, V23, P2735
[6]   The MDR1 (ABCB1) gene polymorphism and its clinical implications [J].
Ieiri, I ;
Takane, H ;
Otsubo, K .
CLINICAL PHARMACOKINETICS, 2004, 43 (09) :553-576
[7]  
Illmer T, 2002, CANCER RES, V62, P4955
[8]   Functional C3435T polymorphism of MDR1 gene:: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia [J].
Jamroziak, K ;
Mlynarski, W ;
Balcerczak, E ;
Mistygacz, M ;
Trelinska, J ;
Mirowski, M ;
Bodalski, J ;
Robak, T .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (05) :314-321
[9]   Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene [J].
Johne, A ;
Köpke, K ;
Gerloff, T ;
Mai, I ;
Rietbrock, S ;
Meisel, C ;
Hoffmeyer, S ;
Kerb, R ;
Fromm, MF ;
Brinkmann, U ;
Eichelbaum, M ;
Brockmöller, J ;
Cascorbi, I ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (05) :584-594
[10]   Identification of functionally variant MDR1 alleles among European Americans and African Americans [J].
Kim, RB ;
Leake, BF ;
Choo, EF ;
Dresser, GK ;
Kubba, SV ;
Schwarz, UI ;
Taylor, A ;
Xie, HG ;
McKinsey, J ;
Zhou, S ;
Lan, LB ;
Schuetz, JD ;
Schuetz, EG ;
Wilkinson, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (02) :189-199